No abstract available
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Anti-Infective Agents / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use
-
Clinical Trials, Phase III as Topic* / ethics
-
Clinical Trials, Phase III as Topic* / methods
-
Drug Industry / ethics
-
Humans
-
Insulin / therapeutic use
-
Multicenter Studies as Topic* / ethics
-
Multicenter Studies as Topic* / methods
-
Placebos
-
Protein C / therapeutic use*
-
Randomized Controlled Trials as Topic* / ethics
-
Randomized Controlled Trials as Topic* / methods
-
Receptors, Interleukin-1 / antagonists & inhibitors
-
Recombinant Proteins / therapeutic use
-
Research Design*
-
Shock, Septic / drug therapy*
-
Shock, Septic / mortality
-
United States / epidemiology
-
United States Food and Drug Administration
Substances
-
Adrenal Cortex Hormones
-
Anti-Infective Agents
-
Antibodies, Monoclonal
-
Insulin
-
Placebos
-
Protein C
-
Receptors, Interleukin-1
-
Recombinant Proteins
-
drotrecogin alfa activated